← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2000Last known activity
Oct 9, 2023
Timeline
1970s
- Jan 1, 1977
Thrasher Research Fund— Founded
Drugs by trial phase (63 distinct, 67 trials)
Phase 4 (12 own, 0 via acquisition)
- diphtheria, tetanus and whole cell pertussis vaccine
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- mebendazole
- quinvaxem
- acellular pertussis vaccine
- ondansetron
- meropenem
- clindamycin
- bivalent oral polio vaccine (bopv), type 1 and type 3
- cephalexin
- human rotavirus, live attenuated
- zinc
Phase 3 (11 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Neonatal
- Anemia, Sickle Cell
- Asphyxia
- Asphyxia Neonatorum
- Asthma
- Autism Spectrum Disorder
- Autistic Disorder
- Blindness
- Brain Diseases
- Brain Ischemia
- Bronchiolitis
- Bronchopulmonary Dysplasia
- Candidiasis
- Cellulitis
- Cholera
- Communicable Diseases
- Corneal Ulcer
- Cystic Fibrosis
- Dehydration
- Developmental Disabilities
- Diarrhea
- Dwarfism
- Fetal Diseases
- Fibrosis
- Folliculitis
- Gastroenteritis
- Gastroesophageal Reflux
- Graft vs Host Disease
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis B
- HIV Infections
- Hypertension
- Hypertension, Pulmonary
- Hypothermia
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infections
- Influenza, Human
- Insulin Resistance
- Intestinal Diseases
- Intestinal Diseases, Parasitic
- Ischemia
- Keratitis
- Leishmaniasis
- Leishmaniasis, Visceral
- Malaria
- Malnutrition
- Obesity
- Parasitic Diseases
- Pneumonia
- Premature Birth
- Pseudomonas Infections
- Rheumatic Diseases
- Rheumatic Heart Disease
- Rotavirus Infections
- Seizures
- Skin Diseases, Infectious
- Staphylococcal Infections
- Staphylococcal Skin Infections
- Tuberculosis
- Ulcer
- Vaginal Diseases
- Vaginosis, Bacterial
- Vitamin D Deficiency
- Vomiting
- Whooping Cough
Recent trials (50)
- NCT06002438CollaboratorN/AOct 9, 2023
- NCT05808166CollaboratorPhase 2May 31, 2023
- NCT03924401CollaboratorPhase 2Aug 31, 2019
- NCT03913221CollaboratorPhase 1Jun 30, 2019
- NCT03908164CollaboratorPhase 4Apr 12, 2019
- NCT03576885CollaboratorPhase 1/Phase 2Sep 30, 2018
- NCT03346525CollaboratorPhase 2Jun 1, 2018
- NCT02995005CollaboratorPhase 1/Phase 2Aug 1, 2017
- NCT02992197CollaboratorPhase 4Jun 12, 2017
- NCT03015610CollaboratorPhase 3Jan 1, 2017
- NCT02621944CollaboratorEarly Phase 1Nov 1, 2016
- NCT02907593CollaboratorPhase 1/Phase 2Sep 1, 2016
- NCT02613169CollaboratorPhase 2Aug 1, 2016
- NCT02589067CollaboratorPhase 2Oct 1, 2015
- NCT02408926CollaboratorPhase 4Apr 1, 2015
Details
- Founded
- Salt Lake City, UT, US Jan 1, 1977
- Last known activity
- Oct 9, 2023